PubMed Health⌕ Search

Biomedical subjects

S S Surana

Publications and source records attributed to S S Surana.

10 recordsLinked to original sources

Ascorbic acid is an abettor in calcium urolithiasis: an experimental study.

Two sets of animal experiments using guinea pigs were planned to evaluate the effect of ascorbic acid supplementation on the lithogenic process. In the first set of experiments, 10, 40, and 60 mg doses of ascorbic acid/100g body weight/day were given for 105 days. Neither of the ascorbic acid doses given induced crystalluria, calcification or stone formation, thereby confirming our previous findings that ascorbic acid in the doses used by clinicians does not cause urolith formation. In the second set of experiments, ascorbic acid was supplemented in hypercalciuric (induced by calcium carbonate feeding) and hyperoxaluric (induced by sodium oxalate feeding) animals for 45 days. The results indicated that it exacerbated the calcification process in renal and bladder tissue.

Animals↗

Effectiveness of a unani therapy (sangesarmahi) in management of urinary stone disease.

A Unani medicine called fish stones, an isolate from the skull of Channa sp. when given to stone bearing patient daily in 3 equally divided doses (25 mg/capsule) for 5 days, spontaneously voided the stone in 36% of the stone patients during 5 days of therapy. The therapy did not influence the urinary chemistry and was not a powerful expulsion agent of stone but did effect on ureteric muscles to facilitate the movement of stone down the urinary tract. In guinea pigs, the therapy could not reduce the intensity of experimentally induced hyperoxaluria but showed several other beneficial effects. It decreased urinary uric acid and mucoprotein levels, serum LDH and ALT level; prevented rise in liver LDH and GAO activities and kidney-LDH activity. Histological examination revealed decreased intensity of calcification in liver, kidney and bladder tissues.

Animals↗

An investigation into the role of ascorbic acid in renal calculogenesis in albino rats.

Neither stone nor calcium oxalate crystal deposition was observed in the kidneys of rats after oral ingestion of 60 mg. L-ascorbic acid daily for three months, although urinary excretion of stone inhibitors (magnesium and citrate) was decreased and oxalate increased. The highly acidic pH of urine and reduced calcium excretion might have prevented their deposition.

Animals↗